IκB kinase 2 determines oligodendrocyte loss by non-cell-autonomous activation of NF-κB in the central nervous system

Brain

Volumn 134, Issue 4, 2011, Pages 1184-1198

  Raasch, Jenni ^a,b   Zeller, Nicolas ^a   Van Loo, Geert ^c,d   Merkler, Doron ^b,e   Mildner, Alexander ^a   Erny, Daniel ^a   Knobeloch, Klaus Peter ^a   Bethea, John R ^f   Waisman, Ari ^g   Knust, Markus ^a   Del Turco, Domenico ^h   Deller, Thomas ^h   Blank, Thomas ^a   Priller, Josef ⁱ   Brück, Wolfgang ^b   Pasparakis, Manolis ^c,j   Prinz, Marco ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY EMBL   (Italy)

^d GHENT UNIVERSITY   (Belgium)

^e GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^f UNIVERSITY OF MIAMI   (United States)

^g JOHANNES GUTENBERG UNIVERSITY   (Germany)

^h GOETHE UNIVERSITY   (Germany)

ⁱ CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^j UNIVERSITY OF COLOGNE   (Germany)

more..

Author keywords

cuprizone; demyelination; glia; multiple sclerosis; NF B; oligodendrocyte; remyelination

Indexed keywords

CUPRIZONE; I KAPPA B KINASE; I KAPPA B KINASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; UNCLASSIFIED DRUG;

ABLATION THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL LOSS; CELL PROTECTION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEMYELINATION; ENZYME ACTIVATION; FEMALE; MOUSE; MYELINATION; NERVE CELL LESION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; SCHWANN CELL; SIGNAL TRANSDUCTION;

EID: 79953672493     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awq359     Document Type: Article

References (51)

1. Acarin L, Gonzalez B, Castellano B. Triflusal posttreatment inhibits glial nuclear factor-kappaB, downregulates the glial response, and is neu-roprotective in an excitotoxic injury model in postnatal brain. Stroke 2001; 32: 2394-402. (Pubitemid 32954814)
2. Arnett HA, Fancy SP, Alberta JA, Zhao C, Plant SR, Kaing S, et al. bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS. Science 2004; 306: 2111-5. (Pubitemid 40007666)
3. Arnett HA, Mason J, Marino M, Suzuki K, Matsushima GK, Ting JP. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci 2001; 4: 1116-22. (Pubitemid 34116557)
4. Bakalkin GY, Yakovleva T, Terenius L. NF-kappa B-like factors in the murine brain. Developmentally-regulated and tissue-specific expression. Brain Res Mol Brain Res 1993; 20: 137-46.
5. Bonetti B, Stegagno C, Cannella B, Rizzuto N, Moretto G, Raine CS. Activation of NF-kappaB and c-jun transcription factors in multiple sclerosis lesions. Implications for oligodendrocyte pathology. Am J Pathol 1999; 155: 1433-8.
6. Brambilla R, Bracchi-Ricard V, Hu WH, Frydel B, Bramwell A, Karmally S, et al. Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury. J Exp Med 2005; 202: 145-56. (Pubitemid 41002917)
7. Brambilla R, Persaud T, Hu X, Karmally S, Shestopalov VI, Dvoriantchikova G, et al. Transgenic inhibition of astroglial NF-kappa B improves functional outcome in experimental autoimmune enceph-alomyelitis by suppressing chronic central nervous system inflammation. J Immunol 2009; 182: 2628-40.
8. Brinkmann BG, Agarwal A, Sereda MW, Garratt AN, Mü ller T, Wende H, et al. Neuregulin-1/ErbB signaling serves distinct functions in myelin-ation of the peripheral and central nervous system. Neuron 2008; 59: 581-95.
9. Bunge RP, Bunge MB, Bates M. Movements of the Schwann cell nucleus implicate progression of the inner (axon-related) Schwann cell process during myelination. J Cell Biol 1989; 109: 273-84. (Pubitemid 19180135)
10. Burbach GJ, Dehn D, Del Turco D, Staufenbiel M, Deller T. Laser micro-dissection reveals regional and cellular differences in GFAP mRNA upregulation following brain injury, axonal denervation, and amyloid plaque deposition. Glia 2004; 48: 76-84. (Pubitemid 39390850)
11. Chariot A. The NF-kappaB-independent functions of IKK subunits in immunity and cancer. Trends Cell Biol 2009; 19: 404-13.
12. De Freitas MS, Spohr TC, Benedito AB, Caetano MS, Margulis B, Lopes UG, et al. Neurite outgrowth is impaired on HSP70-positive astrocytes through a mechanism that requires NF-kappaB activation. Brain Res 2002; 958: 359-70. (Pubitemid 35441189)
13. Dong Y, Benveniste EN. Immune function of astrocytes. Glia 2001; 36: 180-90. (Pubitemid 33055906)
14. Falls DL. Neuregulins: functions, forms, and signaling strategies. Exp Cell Res 2003; 284: 14-30. (Pubitemid 36335807)
15. Gerondakis S, Grumont R, Gugasyan R, Wong L, Isomura I, Ho W, et al. Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models. Oncogene 2006; 25: 6781-99. (Pubitemid 44657852)
16. Gold R, Linington C, Lassmann H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 2006; 129: 1953-71. (Pubitemid 44289062)
17. Gringhuis SI, Garcia-Vallejo JJ, Van Het HB, Van Dijk W. Convergent actions of I kappa B kinase beta and protein kinase C delta modulate mRNA stability through phosphorylation of 14-3-3 beta complexed with tristetraprolin. Mol Cell Biol 2005; 25: 6454-63. (Pubitemid 41023221)
18. Hamanoue M, Yoshioka A, Ohashi T, Eto Y, Takamatsu K. NF-kappaB prevents TNF-alpha-induced apoptosis in an oligodendrocyte cell line. Neurochem Res 2004; 29: 1571-6. (Pubitemid 38860240)
19. Hanisch UK. Microglia as a source and target of cytokines. Glia 2002; 40: 140-55.
20. Hayden MS, Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008; 132: 344-62.
21. Herrmann O, Baumann B, de Lorenzi R, Muhammad S, Zhang W, Kleesiek J, et al. IKK mediates ischemia-induced neuronal death. Nat Med 2005; 11: 1322-9. (Pubitemid 41752913)
22. Hiremath MM, Saito Y, Knapp GW, Ting JP, Suzuki K, Matsushima GK. Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice. J Neuroimmunol 1998; 92: 38-49. (Pubitemid 29015988)
23. Hovelmeyer N, Hao Z, Kranidioti K, Kassiotis G, Buch T, Frommer F, et al. Apoptosis of oligodendrocytes via Fas and TNF-R1 is a key event in the induction of experimental autoimmune encephalomyelitis. J Immunol 2005; 175: 5875-84. (Pubitemid 41508072)
24. Hu MC, Lee DF, Xia W, Golfman LS, Ou-Yang F, Yang JY, et al. IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 2004; 117: 225-37. (Pubitemid 38496242)
25. Huang CJ, Nazarian R, Lee J, Zhao PM, Espinosa-Jeffrey A, de VJ. Tumor necrosis factor modulates transcription of myelin basic protein gene through nuclear factor kappa B in a human oligodendroglioma cell line. Int J Dev Neurosci 2002; 20: 289-96.
26. Jaegle M, Mandemakers W, Broos L, Zwart R, Karis A, Visser P, et al. The POU factor Oct-6 and Schwann cell differentiation. Science 1996; 273: 507-10. (Pubitemid 26286453)
27. Kassmann CM, Lappe-Siefke C, Baes M, Brü gger B, Mildner A, Werner HB, et al. Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes. Nat Genet 2007; 39: 969-76. (Pubitemid 47185174)
28. Li L, Lundkvist A, Andersson D, Wilhelmsson U, Nagai N, Pardo AC, et al. Protective role of reactive astrocytes in brain ischemia. J Cereb Blood Flow Metab 2008; 28: 468-81. (Pubitemid 351304260)
29. Matsushima GK, Morell P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 2001; 11: 107-16.
30. Mattson MP, Camandola S. NF-kappaB in neuronal plasticity and neu-rodegenerative disorders. J Clin Invest 2001; 107: 247-54. (Pubitemid 32162153)
31. Michailov GV, Sereda MW, Brinkmann BG, Fischer TM, Haug B, Birchmeier C, et al. Axonal neuregulin-1 regulates myelin sheath thickness. Science 2004; 304: 700-3. (Pubitemid 38560869)
32. Mildner A, Schmidt H, Nitsche M, Merkler D, Hanisch UK, Mack M, et al. Microglia in the adult brain arise from Ly-6C(hi)CCR2( + ) mono-cytes only under defined host conditions. Nat Neurosci 2007; 10: 1544-53. (Pubitemid 350175884)
33. Nicholas RS, Wing MG, Compston A. Nonactivated microglia promote oligodendrocyte precursor survival and maturation through the transcription factor NF-kappa B. Eur J Neurosci 2001; 13: 959-67. (Pubitemid 32226147)
34. Nickols JC, Valentine W, Kanwal S, Carter BD. Activation of the transcription factor NF-kappaB in Schwann cells is required for peripheral myelin formation. Nat Neurosci 2003; 6: 161-7. (Pubitemid 36182785)
35. Oertle T, van der Haar ME, Bandtlow CE, Robeva A, Burfeind P, Buss A, et al. Nogo-A inhibits neurite outgrowth and cell spreading with three discrete regions. J Neurosci 2003; 23: 5393-406. (Pubitemid 36807813)
36. Ousman SS, David S. Lysophosphatidylcholine induces rapid recruitment and activation of macrophages in the adult mouse spinal cord. Glia 2000; 30: 92-104. (Pubitemid 30172156)
37. Pasparakis M, Courtois G, Hafner M, Schmidt-Supprian M, Nenci A, Toksoy A, et al. TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2. Nature 2002; 417: 861-6. (Pubitemid 34670334)
38. Perkins ND. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 2007; 8: 49-62. (Pubitemid 46012014)
39. Priller J, Flugel A, Wehner T, Boentert M, Haas CA, Prinz M, et al. Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraft-ment. Nat Med 2001; 7: 1356-61. (Pubitemid 34007942)
40. Prinz M, Garbe F, Schmidt H, Mildner A, Gutcher I, Wolter K, et al. Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J Clin Invest 2006; 116: 456-64. (Pubitemid 43228363)
41. Prinz M, Hanisch UK. Murine microglial cells produce and respond to interleukin-18. J Neurochem 1999; 72: 2215-8. (Pubitemid 29186031)
42. Prinz M, Montrasio F, Furukawa H, van der Haar ME, Schwarz P, Rü licke T, et al. Intrinsic resistance of oligodendrocytes to prion infection. J Neurosci 2004; 24: 5974-81. (Pubitemid 38859394)
43. Prinz M, Schmidt H, Mildner A, Knobeloch KP, Hanisch UK, Raasch J, et al. Distinct and nonredundant in vivo functions of IFNAR on mye-loid cells limit autoimmunity in the central nervous system. Immunity 2008; 28: 675-86.
44. Schmid JA, Birbach A. IkappaB kinase beta (IKKbeta/IKK2/IKBKB)-a key molecule in signaling to the transcription factor NF-kappaB. Cytokine Growth Factor Rev 2008; 19: 157-65. (Pubitemid 351382281)
45. Schmidt-Ullrich R, Memet S, Lilienbaum A, Feuillard J, Raphael M, Israel A. NF-kappaB activity in transgenic mice: developmental regulation and tissue specificity. Development 1996; 122: 2117-28. (Pubitemid 26235812)
46. Topilko P, Schneider-Maunoury S, Levi G, Baron-Van Evercooren A, Chennoufi AB, Seitanidou T, et al. Krox-20 controls myelination in the peripheral nervous system. Nature 1994; 371: 796-9. (Pubitemid 24333867)
47. Tronche F, Kellendonk C, Kretz O, Gass P, Anlag K, Orban PC, et al. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet 1999; 23: 99-103. (Pubitemid 29418797)
48. Vallabhapurapu S, Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 2009; 27: 693-733.
49. Van Loo G, De LR, Schmidt H, Huth M, Mildner A, Schmidt-Supprian M, et al. Inhibition of transcription factor NF-kappaB in the central nervous system ameliorates autoimmune encephalomyelitis in mice. Nat Immunol 2006; 7: 954-61. (Pubitemid 44263909)
50. Vollgraf U, Wegner M, Richter-Landsberg C. Activation of AP-1 and nuclear factor-kappaB transcription factors is involved in hydrogen peroxide-induced apoptotic cell death of oligodendrocytes. J Neurochem 1999; 73: 2501-9.
51. Zaheer A, Yorek MA, Lim R. Effects of glia maturation factor overexpres-sion in primary astrocytes on MAP kinase activation, transcription factor activation, and neurotrophin secretion. Neurochem Res 2001; 26: 1293-9. (Pubitemid 34184028)